immunological characterisation of 14 cases of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid: a single centre study.

immunological characterisation of 14 cases of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid: a single centre study. Br J Dermatol. 2019 Sep 09;: Authors: Hayashi M, Tsunoda T Abstract Recently, we analysed a case series of bullous pemphigoid (BP) for antibodies to various domains of BP180 using ELISA and immunoblotting, and showed that dipeptidyl peptidase 4 inhibitor-associated BP (DPP4i-BP) patients tend to demonstrate non-inflammatory phenotype and positive reactivity to midportion of BP180.1 However, the. PMID: 31498425 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31498425?dopt=Abstract

Source: The British Journal of Dermatology - September 8, 2019 Category: Dermatology Authors: Hayashi M, Tsunoda T Tags: Br J Dermatol Source Type: research